Qiagen N.V. (QGEN) Stock Overview
Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.
Qiagen N.V. (QGEN)
Key Financials
Key Financials
Market Cap
10.4B
P/E Ratio
25.84
EPS (TTM)
$2.42
ROE
0.12%
QGEN Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Qiagen N.V. (NYSE: QGEN) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Qiagen N.V.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of QGEN on the NYSE shows an RSI of 74.50, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $45.32 for the NYSE listing.
Key metrics behind Qiagen N.V.'s NYSE-traded stock include a P/E ratio of 25.84 and a market capitalization of 10.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of QGEN on the NYSE.